27 ΜARCH 2021
  PRESIDENTS OF SEMINAR: Konstantinos Dinas, Alexios Papanikolaou, Frederic Guyon   
  ORGANIZING MODERATOR: Stamatios Petousis
08:30-10:00 Round Table 1. Conservative management of gynaecological cancer
  Presidents: Alexios Papanikolaou, Pavlos Papakotoulas
  1.Conservative management of endometrial cancer. When, how, to whom? Anastasios Liberis
  2.Cervical cancer: could chemoradiotheapy replace all surgical treatment? Konstantina Mponiou
  3.Ovarian cancer: could neoadjuvant chemotherapy replace surgery? Anne Floquet - Coriolan Lebreton
  4.Chemotherapy in gynaecological cancer: special considerations in the context of COVID-pandemic Eleni Timotheadou
   
  Commentary: Dimitrios Tsolakidis,  George Androutsopoulos
10:00-11:45 Round Table 2. Minimizing surgical radicality
  Presidents: Alexandros Rodolakis, Evangelos Paraskevaidis
  1. When is lymphadenectomy essential in endometrial cancer surgery? Stamatios Petousis
  2. Laparoscopic sentinel node in endometrial cancer to reduce surgical morbidity: always, sometimes or never? Angelos Daniilidis
  3. Simple hysterectomy instead of radical hysterectomy for early-stage cervical cancer. Does it indeed compromise outcome? Alexios Papanikolaou
  4. Avoiding unnecessary surgical treatment of cervical intraepithelial neoplasia. Why and how? Evangelos Paraskevaidis
  5. Minimally invasive treatment of ovarian cancer: is indeed feasible? Frederic Guyon
   
  Commentary: Ioannis Kalogiannidis, Dimitrios Chaidopoulos, Emmanouil Kontomanolis
11:45-12:00 Break
12:00-12:30 PLENNARY SESSION 1
  President: Frederic Guyon
  COVID-19 era. Has it indeed alter our surgical approach?
  Professor Ranjit Manchanda
12:30-13:00 PLENNARY SESSION 2
  President: Konstantinos Dinas
  Robotic surgery in the treatment of gynaecological cancer during COVID-19 pandemic. What is the added value?
  Dr. Angelos Sioutas
13:00-13:45 Round Table 3.  Optimizing protocols of postoperative treatment
  Presidents: Alexandros Daponte, Eleni Katsika
  1. Lack of Intensive Care Unit availability. How should this change surgical treatment? Dimitris Vaikos
  2. Sarcopeny as modifiable risk factor for ovarian cancer patients. Time to establish as standard care? Chrysoula Margioula-Siarkou -  Jean-Pierre Gekiere
   
  Commentary: George Mavromatidis, Konstantinos Katsanoulas
13:45-14:00 Break
14:00-14:30 PLENARY SESSION 3
  Acquiring ESGO accreditation for 2nd Department of Obstetrics and Gynaecology. The trip to the dream.
  Κonstantinos Dinas
14:30-14:45 PLENARY SESSION 4
  The Importance of Adapting Activities to the Pandemic Reality: the ENYGO Experience
  Zoia Razumova
14:45-15:00 Round Table 4. Multidisciplinary Tumour Board: presentation and live discussion of two   relative cases
  Presentation: Chrysoula Margioula-Siarkou
  Oncological council: Alexios Papanikolaou, Konstantinos Dinas, Frederic Guyon, Angelos Sioutas, Stamatios Petousis, Anastasios Liberis, Pavlos Papakotoulas, Konstantina Mponiou, Stamatia Angelidou
15:00-15:30 CLOSING REMARKS
  Konstantinos Dinas, Alexios Papanikolaou, Stamatios Petousis, Frederic Guyon